Cleared Traditional

K221890 - Elecsys Tg II (FDA 510(k) Clearance)

Sep 2023
Decision
458d
Days
Class 2
Risk

K221890 is an FDA 510(k) clearance for the Elecsys Tg II. This device is classified as a System, Test, Thyroglobulin (Class II - Special Controls, product code MSW).

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on September 30, 2023, 458 days after receiving the submission on June 29, 2022.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K221890 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2022
Decision Date September 30, 2023
Days to Decision 458 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MSW — System, Test, Thyroglobulin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.6010